Annexin Pharmaceuticals AB (OSTO:ANNX) Institutional Ownership : 0.01% (As of Jun. 20, 2024)

View and export this data going back to 2017. Start your Free Trial

What is Annexin Pharmaceuticals AB Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Annexin Pharmaceuticals AB's institutional ownership is 0.01%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Annexin Pharmaceuticals AB's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Annexin Pharmaceuticals AB's Float Percentage Of Total Shares Outstanding is 0.00%.

Annexin Pharmaceuticals AB Institutional Ownership Historical Data

The historical data trend for Annexin Pharmaceuticals AB's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Annexin Pharmaceuticals AB Institutional Ownership Chart

Annexin Pharmaceuticals AB Historical Data

The historical data trend for Annexin Pharmaceuticals AB can be seen below:

	2023-08-31	2023-09-30	2023-10-31	2023-11-30	2023-12-31	2024-01-31	2024-02-29	2024-03-31	2024-04-30	2024-05-31
Institutional Ownership	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01

Annexin Pharmaceuticals AB Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

Annexin Pharmaceuticals AB (OSTO:ANNX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Annexin Pharmaceuticals AB (OSTO:ANNX) » Definitions » Institutional Ownership

Comparable Companies

Traded in Other Exchanges

N/A

Address

Norrtullsgatan 6, Stockholm, SWE, SE-113 29

Website

https://www.annexinpharma.com

Annexin Pharmaceuticals AB is a biotechnology company. It is developing biological drug candidate ANXV, a recombinant human protein Annexin A5 for treatment of various cardiovascular diseases. The company also focuses on development of ANXV for the treatment of retinal vein occlusion.